Under the agreement, Vector Laboratories will provide non-proprietary protein sequences of antibodies having known and disclosed manufacturability issues, such as poor yield and high propensity for ...
Thirty years ago today, 'Eye of the Needle' gave Voyager an impossible scenario, and gave it a perfectly Star Trek solution.
Unity Software (NYSE: U) stock is seeing explosive gains in Thursday's trading. The company's share price was up 28% as of 12 ...
Cardiac arrhythmias affect millions across the world and are responsible for a fifth of all deaths in the Netherlands.
AccelerComm’s 5G NR NTN physical-layer approach employs devices with vector-processing cores for signal processing.
OXB announces that its proprietary lentiviral vector manufacturing technology will be used in Boehringer Ingelheim’s newly initiated LENTICLAIR ...
Iteris, Inc., the world's trusted technology ecosystem for smart mobility infrastructure management and part of Almaviva Group, today announced the United States District Court for the Western ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
New York City council data scientist says organisations should get their hands dirty with open source AI as his teams build ...
Your phone is at risk as cybercriminals shift to a “mobile-first attack strategy,” having discovered you are far more likely ...
The growing imbalance between the amount of data that needs to be processed to train large language models (LLMs) and the ...
12h
News Medical on MSNBreakthrough in gene therapy could help protect against heart arrhythmiasCardiac arrhythmias affect millions across the world and are responsible for a fifth of all deaths in the Netherlands.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results